Both speakers affirmed the potential of Taiwan's capital market. As of April 2025, Taiwan's equity market had a total capitalization of NT$65.09 trillion ... collaborating with innovative companies to ...

With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers. Revenue Challenges: Vir Biotechnology's revenue growth ...

Q1 total crypto market cap & trading volume chart. Source: CoinGecko The report further explains that the BTC continued to climb in dominance, increasing by 4.6% in Q1 and ending the quarter with ...

(Image/Reuters) With a 40.84% rise in its share price, Bharti Airtel’s market cap soared Rs 3.10 lakh crore in fiscal 2025, emerging as the top wealth creator. Many brokerages remain bullish on ...

Total crypto market cap chart. Source: CoinGecko The graph below shows that major cryptocurrencies like BTC, ETH, XRP and SOL fell 5.9%, 10.9%, 15% and 10.1%, respectively, in the last 7 days.

Stock market: Indian retail investors, who have actively invested in mid- and small-cap stocks in recent years due to their relatively low trading prices compared to large caps, now seem to be ...

Bitcoin and Global Liquidity Index. Source: X As illustrated in the chart, Quant explained that the GLI and the TOTAL market cap carried a strong 0.77 correlation with a 74-day offset. With the ...

This triggered massive selloffs in megacap stocks. Nvidia (NVDA) fell 17%, losing over $500 billion in market capitalization -- a record-breaking decline, larger than the entire market cap of ...

The Association of Mutual Funds in India (Amfi) recently released the updated half-yearly data on market capitalization classifications for listed stocks. As defined by the Securities and Exchange ...

Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple ...

Investing.com -- Shares of Vir Biotechnology, Inc. (NASDAQ:VIR) surged 29% following the release of encouraging safety and efficacy data from ongoing dose escalation trials for its dual-masked T-cell ...

VIR-5500 achieved PSA reductions in 100% of prostate cancer patients, with a 58% PSA50 response at doses ≥120 µg/kg. Rebound or breakdown? See how Matt Maley is trading June’s market ...